Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-002274-28Phase 4Completed
Phase 4, single-arm trial of cholecalciferol in coronavirus disease 2019 (COVID-19), sponsored by FINBA. Primary endpoints: Percentage of patients with negative SARS-CoV-2 viral load and Time to negative SARS-CoV-2 viral load. Started May 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-002274-28.